GAROSI, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 3.766
NA - Nord America 3.640
AS - Asia 2.437
SA - Sud America 378
AF - Africa 165
OC - Oceania 10
Totale 10.396
Nazione #
US - Stati Uniti d'America 3.566
RU - Federazione Russa 924
IT - Italia 834
CN - Cina 773
SG - Singapore 715
IE - Irlanda 542
GB - Regno Unito 526
BR - Brasile 314
VN - Vietnam 238
SE - Svezia 200
FR - Francia 192
HK - Hong Kong 192
DE - Germania 183
KR - Corea 176
BD - Bangladesh 114
UA - Ucraina 108
FI - Finlandia 90
ZA - Sudafrica 89
IN - India 85
ES - Italia 35
CA - Canada 33
TR - Turchia 28
PL - Polonia 24
RO - Romania 23
MA - Marocco 22
MX - Messico 22
NL - Olanda 21
AR - Argentina 20
IQ - Iraq 19
JP - Giappone 16
CI - Costa d'Avorio 14
AT - Austria 13
KE - Kenya 13
PK - Pakistan 12
BE - Belgio 10
AU - Australia 9
CL - Cile 8
CO - Colombia 8
EC - Ecuador 8
IR - Iran 8
JM - Giamaica 7
SA - Arabia Saudita 7
SI - Slovenia 7
ID - Indonesia 6
TN - Tunisia 6
VE - Venezuela 6
CH - Svizzera 5
MY - Malesia 5
SN - Senegal 5
CR - Costa Rica 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
PE - Perù 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AZ - Azerbaigian 3
ET - Etiopia 3
HR - Croazia 3
LV - Lettonia 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 10.389
Città #
Dublin 539
Dallas 476
Southend 418
Singapore 390
Chandler 294
Ashburn 274
Moscow 259
Hefei 251
Santa Clara 246
San Jose 222
Fairfield 196
Hong Kong 183
Seoul 175
Siena 171
Beijing 165
Woodbridge 98
Ann Arbor 89
Seattle 87
Jacksonville 85
Johannesburg 84
Ho Chi Minh City 81
Los Angeles 78
Cambridge 76
Houston 70
Milan 68
Wilmington 68
The Dalles 65
Florence 59
New York 59
Menlo Park 58
Lauterbourg 57
Hanoi 52
Helsinki 46
Boardman 44
Princeton 39
Bengaluru 38
Munich 37
Nanjing 35
Council Bluffs 34
Rome 31
Buffalo 28
São Paulo 28
Orem 27
Shanghai 24
Redondo Beach 22
Dearborn 21
Frankfurt am Main 20
Turku 20
Warsaw 19
San Diego 18
San Mateo 18
Messina 17
Stockholm 16
Washington 16
Abidjan 14
Brooklyn 14
Chicago 14
Iesi 14
Izmir 14
London 14
Nuremberg 14
Bologna 13
Montreal 13
Málaga 13
Rio de Janeiro 13
Tianjin 13
Tokyo 13
Amsterdam 11
Chennai 11
Denver 11
Toronto 11
Casablanca 10
Da Nang 10
Marrakesh 10
Phoenix 10
Casalecchio di Reno 9
Columbus 9
Lappeenranta 9
Naples 9
Poplar 9
Prato 9
Brescia 8
Brussels 8
Hillsboro 8
San Francisco 8
Dong Ket 7
Haiphong 7
Istanbul 7
Ljubljana 7
Madrid 7
Mexico City 7
Mumbai 7
Paris 7
Saronno 7
Vienna 7
Baghdad 6
Boston 6
Brasília 6
Changsha 6
Codogno 6
Totale 6.537
Nome #
null 398
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 350
Alport syndrome: impact of digenic inheritance in patients management 312
HCMV infection in renal transplant recipients: a retrospective cohort study 281
Clinical and MRI improvement in a case of progressive multifocal leukoencephalopathy 274
Advances in Alport syndrome diagnosis using next-generation sequencing 263
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 257
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience 255
Epidemiologic study of neonatal jaundice. A survey of contributing factors 243
Expert consensus guidelines for the genetic diagnosis of Alport syndrome 233
Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies 221
Detection of cryptic mosaicism in X-linked alport syndrome prompts to re-evaluate living-donor kidney transplantation 221
Evaluation of renal functional reserve with oral protein load or new ultrasound test 220
SARS-CoV-2 in pleural fluid in a kidney transplant patient 219
Deep Learning Approaches for the Segmentation of Glomeruli in Kidney Histopathological Images 208
Base genetica della microangiopatia trombotica post-trapianto di midollo: l’ultimo tassello del puzzle? [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?] 194
Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variant 193
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 192
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant 191
Brief Communication PD1-related Nephrotoxicity: Optimizing Its Clinical Management Through Histopathologic Features 190
Rationale for the evaluation of renal functional reserve in allogeneic stem cell transplantation candidates: a pilot study 183
null 182
Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy 179
Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine 178
Letter to the Editor: Kidney Transplantation and Obesity are There Any Differences in Outcomes? 176
Unusual presentation of secondary syphilis: membranoproliferative glomerulonephritis andmuco-cutaneous lesions 172
Il ruolo dell'infezione da CMV e del suo monitoraggio attivo nella nuova era dei trapianti di rene: risultati di una coorte completa 171
Diagnosis, treatment, and follow-up of patients with cerebral amyloid angiopathy-related inflammation 168
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 157
Minimal change disease following vaccination for SARS-CoV-2 156
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 156
Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure. 149
Biocompatibility of a peritoneal dialysis solution with amino acids: Histological evaluation in the rabbit 142
THE EVALUATION OF RENAL FUNCTIONAL RESERVE WITH ORAL PROTEIN LOAD OR ULTRASOUND TEST: A REAL-LIFE PERSPECTIVE 139
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure 139
A new self-locating peritoneal catheter 137
Atlas of Peritoneal Histology 129
Kidney vascular damage and cocaine 129
Dalla Mailing-List soci SIN (ML-SIN): la sclerosi peritoneale [From the Mailing List SIN: peritoneal sclerosis] 122
Primo Case Report di utilizzo dell’Ofatumumab nel trapianto renale AB0 incompatibile [First case report of using Ofatumumab in kidney transplantation AB0 incompatible] 122
Dalla Mailing-List soci SIN (ML-SIN). La sclerosi peritoneale: terapia e prevenzione [From the Mailing List SIN: Therapy and prevention of peritoneal sclerosis] 118
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome 116
Clinical effects of biocompatible dialysis fluids 115
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group 113
Dialisi peritoneale: metodica a termine a causa della peritonite sclerosante? No, ma ci sono approcci migliori. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis? No, but better approaches are available] 112
Videothoracoscopic obliteration of pleuroperitoneal fistula in continuous peritoneal dialysis 112
Different Aspects of Peritoneal Damage: Fibrosis and Sclerosis 111
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 111
Using Renal Elastography to Predict the Therapeutic Response of Nephrological Patients 110
A collaborative approach to understanding EPS: The European perspective 110
Encapsulating peritoneal sclerosis 104
Health-Related Quality of Life in pre-dialysis patients with chronic kidney disease: the role of Big-Five personality traits and illness denial 101
Sclerosing peritonitis: A nosological entity 95
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 95
Simple peritoneal sclerosis and sclerosing peritonitis: related or distinct entities? 89
RENAL FUNCTIONAL RESERVE AS A MARKER TO STRATIFY THE RISK OF KIDNEY INJURY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION 86
Omental milky spots and peritoneal dialysis - Review and personal experience 85
The social cost of chronic kidney disease in Italy 82
Mesothelial biocompatibility of peritoneal dialysis solutions 81
Morphological aspects of peritoneal sclerosis 80
The rabbit model in evaluating the biocompatibility in peritoneal dialysis 77
The peritoneal dialysis catheter 76
Peritoneal sclerosis: One or two nosological entities? 76
Effetto del naloxone e del naltrexone sulla spesa energetica post-prandiale e sulla risposta del pancreas endocrino ad un pasto misto nell'obesita essenziale. [Effect of naloxone and naltrexone on the postprandial energy expenditure and endocrine pancreas response to a mixed meal in essential obesity] 73
Encapsulating Peritoneal Sclerosis - Comment on the 8th GPDP-SIN 2022 Census data 64
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis 62
Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study 37
null 31
null 2
null 1
Totale 10.526
Categoria #
all - tutte 34.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 0 54
2021/2022427 38 54 26 46 12 17 14 17 23 40 46 94
2022/20231.049 25 66 123 138 117 234 30 98 120 24 54 20
2023/2024884 25 19 55 36 46 228 282 41 16 17 14 105
2024/20251.836 26 72 146 78 230 135 60 86 169 77 178 579
2025/20264.339 391 654 375 562 872 170 506 138 109 250 150 162
Totale 10.526